Aggressive behavior of classical Kaposi's sarcoma and coexistence with angiosarcoma

Journals of Gerontology - Series A Biological Sciences and Medical Sciences

Volumn 60, Issue 4, 2005, Pages 520-523

  Gambassi, Giovanni ^a,b   Semeraro, Roberto ^c   Suma, Vincenzo ^d   Sebastio, AnnaMaria ^d   Incalzi, Raffaele Antonelli ^a  

^a CATHOLIC UNIVERSITY   (Italy)

^b BROWN UNIVERSITY   (United States)

^c Residenza Sanitaria Assistenziale Cittadella Della Carit   (Italy)

^d Azienda Ospedaliera SS Annunziata   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFECTIVE AGENT; VINBLASTINE;

AGED; AGGRESSION; ANAMNESIS; ANGIOSARCOMA; ARTICLE; ARTIFICIAL FEEDING; CASE REPORT; CHEMOTHERAPY; CLINICAL FEATURE; GASTROINTESTINAL HEMORRHAGE; HISTOLOGY; HUMAN; HUMAN HERPESVIRUS 8; KAPOSI SARCOMA; MALE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; SEROLOGY; SKIN BIOPSY;

HERPES; HERPES VIRUS TYPE 8; HERPESVIRIDAE; HUMAN HERPES VIRUS;

EID: 19044371498     PISSN: 10795006     EISSN: None     Source Type: Journal    
DOI: 10.1093/gerona/60.4.520     Document Type: Article

References (29)

1. Cottoni F, De Marco R, Montesu MA. Classical Kaposi's sarcoma in north-east Sardinia: an overview from 1977 to 1991. Br J Cancer. 1996;73:1132-1133.
2. Wahman A, Melnick SL, Rhame FS. The epidemiology of classic, African and immunosuppressed Kaposi's sarcoma. Epidemiol Rev. 1991;13:178-199.
3. Weissmann A, Linn S, Weltfriend S, Friedman-Birnbaum R. Epidemiological study of classic Kaposi's sarcoma: a retrospective review of 125 cases from Northern Israel. J Eur Acad Dermatol Venereol. 2000;14:91-95.
4. Ensoli B, Sturzl M. Kaposi's sarcoma: a result of the interplay among inflammatory cytokines, angiogenic factors and viral agents. Cytokine Growth Factor Rev. 1998;9:63-83.
5. Weninger W, Partanen TA, Breiteneder-Geleff S, et al. Expression of vascular endothelial growth factor receptor-3 and podoplanin suggest a lymphatic endothelial cell origin of Kaposi's sarcoma tumor cells. Lab Invest. 1999;79:243-251.
6. Moore PS, Chang Y. Detection of herpesvirus-like DNA sequences in Kaposi's sarcoma in patients with and those without infection. N Engl J Med. 1995;332:1181-1185.
7. Dupin N, Grandadam M, Calvez V, et al. Herpesvirus-like DNA sequences in patients with Mediterranean Kaposi's sarcoma. Lancet. 1995;345:761-762.
8. Bisceglia M, Bosman C, Carlesimo OA, Innocenzi D, Quirke P. Kaposi's sarcoma: a clinico-pathologic overview. Tumori. 1991;77:291-310.
9. Friedman-Kein A, Saltzman BR. Clinical manifestations of classical, endemic African, and epidemic AIDS-associated Kaposi's sarcoma. J Am Acad Dermatol. 1990;22:1237-1250.
10. Brenner B, Weissmann-Brenner A, Rakowsky E, et al. Classical Kaposi sarcoma: prognostic factor analysis of 248 patients. Cancer. 2002;95:1982-1987.
11. Lospalluti M, Mastrolonardo M, Loconsole F, Conte A, Rantuccio F. Classical Kaposi's sarcoma: a survey of 163 cases observed in Bari, south Italy. Dermatology. 1995;191:104-108.
12. Cossu S, Satta R, Cottoni F, Massarelli G. Lymphangioma-like variant of Kaposi's sarcoma: clinicopathologic study of seven cases with review of the literature. Am J Dermatopathol. 1997;19:16-22.
13. Boneschi V, Brambilla L, Berti E, et al. Human herpesvirus 8 DNA in the skin and blood of patients with Mediterranean Kaposi's sarcoma: clinical correlations. Dermatology. 2001;203:19-23.
14. Chapman SM, Bell SJ, Chen S, Cosolo W. Classical Kaposi's sarcoma: a rare cause of gastrointestinal haemorrhage. J Gastroenterol Hepatol. 1996;11:408-410.
15. Just Sarobe M, Ribera Pibernat M, Lopez Cabrerizo MP, Urrutia de Diego A, Ferrandiz Foraster C. Classical Kaposi sarcoma of aggressive corse. Rev Clin Esp. 1998;198:95-98.
16. Koliios G, Kaloterakis A, Filiotou A, Nakos A, Hadziyannis S. Gastroscopic findings in Mediterranean Kaposi's sarcoma. Gastrointest Endosc. 1995;42:336-339.
17. Piette WW. The incidence of second malignancies in subsets of Kaposi's sarcoma. J Am Acad Dermatol. 1987;16:855-861.
18. Steiner MC, Smith ME, Spittle MF. A patient with classical Kaposi's sarcoma and angiosarcoma: bad luck or common aetiology? Clin Oncol. 1997;9:186-188.
19. McDonagh DP, Liu J, Gaffey MJ, Layfield LJ, Azumi N, Traweek ST. Detection of Kaposi's sarcoma-associated herpesvirus-like DNA sequence in angiosarcoma. Am J Pathol. 1996;149:1363-1368.
20. Percy C, Van Holten V, Muir C, eds. International Classification of Diseases for Oncology (ICD-O), 2nd Ed. Geneva (Switzerland): World Health Organization; 1990.
21. Fanburg-Smith JC, Furlong MA, Childers EL. Oral and salivary gland angiosarcoma: a clinicopathologic study of 29 cases. Mod Pathol. 2003;16:263-271.
22. Cooper JS, Sacco J, Newall Y. The duration of local control of classic (non-AIDS-associated) Kaposi's sarcoma by radiotherapy. J Am Acad Dermatol. 1988;19:59-66.
23. Brenner B, Rakowsky E, Katz A, et al. Tailoring treatment for classical Kaposi's sarcoma: comprehensive clinical guidelines. Int J Oncol. 1999;14:1097-1102.
24. Tur E, Brenner S. Classic Kaposi's sarcoma: low-dose interferon alfa treatment. Dermatology. 1998;197:37-42.
25. Zidan J, Robenstein W, Abzah A, Tamam S. Treatment of Kaposi's sarcoma with vinblastine in patients with disseminated dermal disease. IMAJ. 2001;3:251-253.
26. Sgadari C, Toschi E, Palladino C, et al. Mechanism of paclitaxel activity in Kaposi's sarcoma. J Immunol. 2000;165:509-517.
27. Northfelt DW, Dezube BJ, Thommes JA, et al. Pegylated-liposomal doxorubicin versus doxorubicin, bleomycin and vincristine in the treatment of AIDS-related Kaposi's sarcoma: results of randomized phase III clinical trial. J Clin Oncol. 1998;16:2445-2451.
28. Tavio M, Nasti G, Simonelli C, et al. Human chorionic gonadotropin in the treatment of HIV-related Kaposi's sarcoma. Eur J Cancer. 1998;34:1634-1637.
29. Toschi E, Sgadari C, Monini P, et al. Treatment of Kaposi's sarcoma: an update. Anticancer Drugs. 2002;13:977-987.